Diamonds and Dogs


Bristol-Myers (BMY) breaking out to new 52 week high. Bristol is up 5% thanks to positive Phase 3 data on the Opdivo-Yervoy combination therapy demonstrating superior progression-free survival over chemotherapy. These drugs will play a meaningful role in first-line lung cancer, which is the largest cancer market. The Morgan Stanley analyst upgraded the stock with a $78 price target.

NetApp (NTAP) taking a hit following earnings.The networking and data storage company is down 10% to a three month low following earnings. The earnings were actually better than expected, but a reduction in gross margins is spooking shareholders concerned about an impact to profitability down the road. NetApp is the second-largest company in the data storage industry, behind Dell EMC, part of Dell Technologies (DVMT). The company has undergone a product transition as industry trends move to chip-based flash storage, cloud computing and newer forms of networking.


Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.